Journal of Internal Medicine and Health Affairs

Abstract

To promote the quality of nursery, continuing education is indispensable. Broadening and continuing education for nurses should be top priority. The different backgrounds and educational status of nurses could be all emphasized in the clinic. This editorial outline these topics of nursery disciplines worldwide.

Introduction

To promote the quality of nursery, continuing education is indispensable. Broadening and continuing education for nurses should be top priority. The different backgrounds and educational status of nurses could be all emphasized in the clinic. This editorial outline these topics of nursery disciplines worldwide. Today, a half of major diseases are chronic diseases. Their treatments and recovery processes were growing dependent on nursery services and capability 1-12. It is the efforts of both doctors and nursing 12-21. Several landscape of different disciples or platforms could be promoted by updating nursery education in schools and hospitals.

2. Diversity of Medical Knowledge

Medical knowledge for nursery is diversity and continuing 11-38. Many clinical steps are proposed (Table 1).

Table 1. Pathways for Mutual Trust between Doctors and Nurses

In summary, different types of nursery, such as suicide prevention 39-43, bone diseases 44-50, metabolic diseases 51-57, neural and mental diseases 58-60, emergence 61-65, cancer 66-70, herbal medicine 71-77 and so on are reiterated. They can promote their practice by fundamental medical knowledge promotion (Table2)

Table 2. Basic Nursery Knowledge

3. Discussion

At present, world hospitals are divided into different categories. In the future, if there is a possible that different medical systems can be used for different hospitals and different patients 11. Thus, optimized treatment can be provided by experienced nurses in remote hospitals and telemedicine. To remote areas of China, many new steps could be introduced. Position suitability for different kinds of nurses having different backgrounds of education, working experience and personal conditions should be balanced in clinical treatments. Better organization of different backgrounds of nurses may be useful for promoting nursery services.

4. Conclusion

Nursery service plays vital role for clinical treatments. Studying its underlying mechanisms has multiple benefiting, especially in some low-tier hospitals and healthcare centers. The education for nurses may achieve unexpected outcomes in clinical trials and patient’s recovery.

References

1. Lu DY, Chen YZ, Lu DF, Che JY. Patient’s care and nursery in different diseases. Hospice & Palliative Medicine International Journal. 2019, 3 (1), 28-30
   View at Publisher | View at Google Scholar
2. Lu DY, Chen YZ, Lu DF. Nursery education, capability and service promotion. Open Access J Nursery. 2019, 2 (3), 1-4
   View at Publisher | View at Google Scholar
3. Lu DY, Chen YZ, Lu DF. Nursery education in schools, significance for career. Biomed Res & Rev. 2019, 2 (2) 113 DOI: 10.31021/bbr.20192113
   View at Publisher | View at Google Scholar
4. Iqbal U, Humayyn A, Li YC. Healthcare quality improvement and measurement strategies and its challenges ahead. Int J Quality in Health Care.
   View at Publisher | View at Google Scholar
5. Iqbal U, Rabrenovic M, Li YC. Healthcare quality challenges in low- and middle-income countries. 2019, 31 (3)
   View at Publisher | View at Google Scholar
6. Leebov W, Scott G. Service quality improvement. The customer satisfaction strategy for healthcare. J Healthcare Quality. 1996, 18 (4), 35
   View at Publisher | View at Google Scholar
7. Lu DY, Chen YZ, Lu DF. Nursery service, quality promotion. Hospice & Palliative Medicine International J. 2019, 3 (3), 97-98
   View at Publisher | View at Google Scholar
8. Lu DY, Chen YZ, Lu DF. Nursery service, quality promotion. Hospice & Palliative Medicine International J. 2019, 3 (3), 97-98
   View at Publisher | View at Google Scholar
9. Lu DY, Chen YZ, Lu DF, Che JY. Nursery service in modern day. Adv Biomedical Engineering Biotechnology. 2019, 1 (3), 1-2 ABED.MS.ID.000515
   View at Publisher | View at Google Scholar
10. Ghaffari M. Building a community of learners: Lessons learned. Nursery Practice and Health Care. 2019, 1 (1), 104
    View at Publisher | View at Google Scholar
11. Lu DY, Chen YZ, Lu DF. Nursery promotion, education and system updating. Int J Multidisciplinary Res Updates. 2022, 3 (1), 1-6
    View at Publisher | View at Google Scholar
12. Lu DY, Chen YZ, Lu DF. Nursery education in schools, significance for career. Biomed Res & Rev. 2019, 2 (2) 113 DOI: 10.31021/bbr.20192113
    View at Publisher | View at Google Scholar
13. An Old Disease, A New Insights. Ed, Shamm Ahmad, 2013, Springer Science, US (ISBN 978-1-4614-5440-3)
    View at Publisher | View at Google Scholar
14. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes; a 21st century challenge. Lancet Diabetes Endocrinol. 2014, 2, 56-64
    View at Publisher | View at Google Scholar
15. Grimaccia F, Kanavos P. Cost, outcome, treatment pathways and challenges for diabetes care in Italy. Global Health, 2014, 10(1): 58
    View at Publisher | View at Google Scholar
16. Lu DY. Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed Da-Yong Lu, Nova Science Publishers, 2017, New York, US (ISBN-978-1-53610-601-5)
    View at Publisher | View at Google Scholar
17. Lu DY. HIV/AIDS Treatments, Fight for a Cure. LAMBERT Academic Publishing. Ed Da-Yong Lu, 2017, Germany (ISBN-978-3-330-07665-5)
    View at Publisher | View at Google Scholar
18. Lu DY. Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics. 2014, Woodhead Publishing, Elsevier, UK (ISBN 978-0-08-100346-6)
    View at Publisher | View at Google Scholar
19. Lu DY, Chen XL, Ding J. Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination—an effective strategy to improve clinical treatment. Medical Hypotheses. 2006, 66(1): 45-51
    View at Publisher | View at Google Scholar
20. Lu DY, Lu TR. Drug sensitivity testing, a unique drug selection strategy. Advances in Biomarker Sciences and Technology, 2020, 2, 59-66 10.1016/j.abst.2020.11.001
    View at Publisher | View at Google Scholar
21. Lu DY, Lu TR, Che JY, Shen Y, Yarla NS. Individualized cancer therapy, future approaches. Current Pharmacogenomics & Personalized Medicine. 2018, 16 (2), 156-163
    View at Publisher | View at Google Scholar
22. Lu DY, Chen YZ, Lu DF. Nursery education, narrow-range or wide-range. Nursing & Care Open Access Journal. 2020, 7 (4), 87-89 DOI:10.15406/ncoaj.2020.07.00225
    View at Publisher | View at Google Scholar
23. Lu DY, Chen YZ, Lu DF. Nursery activity and quality, chemistry between doctors and nurses. Nursing & Care Open Access Journal. 2020, 7 (4), 91-93 DOI:10.15406/ncoaj.2020.07.00226
    View at Publisher | View at Google Scholar
24. Lu DY, Che JY, Putta S. Obese study, keep up the momentum. Int J Endocrinology Res. 2018, 1 (1), 1-3
    View at Publisher | View at Google Scholar
25. Che JY, Xu B, Lu DY. Human obesity and diabetes, is it associated with COVID-19 mortality. EC Diabetes and Metabolic Research. 2020, 4 (11),
    View at Publisher | View at Google Scholar
26. Lu DY, Che JY, Yarla NS, Putta S, Lin LP, Shen Y. Human obesity, pathological and therapeutic advances. EC Pharmacology & Toxicology. 2019, 7 (4), 231-238
    View at Publisher | View at Google Scholar
27. Lu DY, Che JY, Shen Y. Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics. 2018, 9 (11), 781-782
    View at Publisher | View at Google Scholar
28. Lu DY, Che JY, Shen ZM, Tong LJ, Lin LP, Shen Y. Osteoporosis treatments for old people. EC Orthopeadicis. 2019, 10 (5), 278-280
    View at Publisher | View at Google Scholar
29. Lu DY, Zhu PP, Lu TR, Che JY. The suicidal risks and treatments, seek medications from multi-disciplinary. Cent Nerv Syst Agents Med Chem. 2016,16 (3), 231-239
    View at Publisher | View at Google Scholar
30. Lu DY, Wu HY. Neuropsychiatric insights for human suicide. Int J Scientific Res Updates. 2021, 1 (2), 11-18 10.53430/ijsru.2021.1.2.0031
    View at Publisher | View at Google Scholar
31. Seimenis, A. (2003): Overview of the epidemiological situation on echinococcosis in the Mediterranean Region. Acta Trop. 85:191-195.
    View at Publisher | View at Google Scholar
32. Lu DY, Lu TR, Wu HY, Yarla NS, Ding J, Xu B. HIV/AIDS curable study, new forms of therapeutic trinity. Rec Pat Antiinfect Drug Discov 2018, 13 (3), 217-227
    View at Publisher | View at Google Scholar
33. Lu DY, Wu HY, Lu TR. HIV/AIDS treatment, therapeutic strategy breakthroughs. Hospice Palliative Medicine International J. 2020, 4 (2), 34-39 DOI10.15406/hpmij.2020.04.00182
    View at Publisher | View at Google Scholar
34. Lu DY, Che JY, Lu TR, Wu HY. Coronavirus (COVID-19), origin, infectivity, epidemics, therapeutics and global impacts. EC Pharmacology & Toxicology. 2021, 9 (3), 100-107
    View at Publisher | View at Google Scholar
35. Lu DY, Wu Hy, Yarla NS, Lu TR, Xu B, Ding J. Ebola therapeutic study and future trends. Infect Disorder Drug Targets. 2019, 19 (1), 17-29
    View at Publisher | View at Google Scholar
36. Prityko DA, Burkov IV, Safonov VV, Klimov DE, Gusev L. Palliative care for children, problems and ways to solve them. EC Clinical & Experimental anatomy. 2019, 2 (9), 23-29
    View at Publisher | View at Google Scholar
37. Lu DY, Chen YZ, Shen Y, Xu B, Lu DF. Medical treatment for chronic or aggressive diseases, palliative therapy and nursery. Novel Res Science. 2020, 3 (2), 556 DOI: 10.31031/NRS.2020.3.000556
    View at Publisher | View at Google Scholar
38. Serafini, G.; Salano, P.; Amore, M. Suicidal ideation: a comprehensive overview. Suicidal Ideation: Predictors, Prevalence and Prevention. Ed. Bradley Weaver. Nova Science Publishing. US, 2015, Chapter 1, pp1-42
    View at Publisher | View at Google Scholar
39. While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, Show J, Appleby L, Kapur N. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet, 2012, 379:1005-1012
    View at Publisher | View at Google Scholar
40. Lu DY, Lu TR, Lu Y, Cao S. Introduction for suicide study. Journal Metabolic Syndrome. 2017, 6 (2), 227
    View at Publisher | View at Google Scholar
41. Lu DY, Shen Y, Cao S. High quality treatments for human suicidal events and mortality. Advanced Techniques in Biology & Medicine. 2020, 8 (2), 269 10.35248/2379-1764.8.2.270
    View at Publisher | View at Google Scholar
42. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, Lu TR. Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem. 2018, 18 (3) 206-212 44. Melton J. “Hip fracture; a worldwide problem today and tomorrow” Bone, 1993, 14;S1-8
    View at Publisher | View at Google Scholar
43. Silva DMW. Diagnosis of osteoporosis; bone mineral density, risk factors, or both”. EC Orthopaedics. 2018, 9 (7), 500-502
    View at Publisher | View at Google Scholar
44. Lu DY, Che JY, Shen Y. Osteoporosis in old women, therapeutic selection. EC Orthopaedics 2018, 9 (7), 386
    View at Publisher | View at Google Scholar
45. Lu DY, Che JY. Bone disease treatment, an editorial. EC Orthopeadics. 2020, 11 (8), 143-145
    View at Publisher | View at Google Scholar
46. Lu DY, Che JY. Bone disease treatments, technical advances. EC Orthopeadics. 2020, 11 (10), 1-3
    View at Publisher | View at Google Scholar
47. Lu DY, Che JY, Shen Y. Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics. 2018, 9 (11), 781-782
    View at Publisher | View at Google Scholar
48. Negm SH. The possible protective role of powder cuttlefish bone, crab shell and eggshell on osteoporotic rats. J Food and Diary Science. 2018, 9 (10), 111-121
    View at Publisher | View at Google Scholar
49. Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, Lu DY, et al. Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications. Current Pharmaceutical Design. 2017, 23(41), 6321-6346 PMID: 28831925
    View at Publisher | View at Google Scholar
50. Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, Xu B, Putta S. Type 2 diabetes study, introduction and perspective. The Open Diabetes Journal. 2018, 8, 13-21
    View at Publisher | View at Google Scholar
51. Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, Xu B, Wu SY, Ding J, Lu Y, Zhu H. Type 2 diabetes treatment and drug development study. The Open Diabetes J. 2018, 8, 22-33
    View at Publisher | View at Google Scholar
52. Lu DY, Chen YZ, Lu DF. Nursery education for diabetes. Nursing & Care Open Access J. 2020, 7 (2), 35-37
    View at Publisher | View at Google Scholar
53. Lu DY, Che JY, Lu Y, Yarla NS, Xu B, Wu SY, Huang YK, Lu DF. An overview of obesity. Metabolomics. 2018, 8(2), 200
    View at Publisher | View at Google Scholar
54. Lu DY, Che JY, Wu HY, Yarla NS, Xu B, Wu SY, Huang YK, Lu TL, Lu DF. Obesity, risks and managements. Metabolomics. 2018, 8(1), e156
    View at Publisher | View at Google Scholar
55. Lu DY, Che JY, Lu TR, Lu Y, Huang YK, Lu TL, Chen YZ, Wu HY, Lu DY. Pathology and treatments of obesity. Trends in Medicine. 2018, 8 (5), 157
    View at Publisher | View at Google Scholar
56. Calik T, Yalmaz V, Unalp A. Nursing approaches in pediatric epilepsy and ketogenic diet treatment. EC Paediatrics. 2020, 7 (8), 110-115
    View at Publisher | View at Google Scholar
57. Lu DY, Shen Y, Xu B. Heart and brain stroke, a paramount task for emergency medication. EC Emergency Medicine and Critical Care. 2019, 3 (10), 785
    View at Publisher | View at Google Scholar
58. Khan M, Silver B. Editorial：Stroke in elderly: current status and future direction. Frontier in Neurology, 2019, 10, 177
    View at Publisher | View at Google Scholar
59. Lu DY, Cao S, Xu B, Shen Y. Bone surgery with bone anatomy analysis. EC Clinical Experimental Anatomy. 2020, 3 (1), 1-4
    View at Publisher | View at Google Scholar
60. Lu DY, Shen Y, Xu B. Cardiovascular emergency, future direction. Int J Clin Med Cases. 2020, 3 (3), 135 DOI: 10.31021/ijcmc.20203135
    View at Publisher | View at Google Scholar
61. Lu DY, Shen Y, Xu B. Cardiovascular emergency, risk factor and improvement. EC Emergency Medicine & Critical Care. 2020, 4 (3), 1-2
    View at Publisher | View at Google Scholar
62. Lu DY, Shen Y, Xu B. Brain stroke, emergency management and drug developments. EC Pharmacology Toxicology, 2019, 7 (11),
    View at Publisher | View at Google Scholar
63. Lu DY, Lu TR, Wu HY, Cao S. Cancer Metastasis treatments. Current Drug Therapy, 2013, 8(1), 24-29
    View at Publisher | View at Google Scholar
64. Lu DY, Xu B, Ding J. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacology, 2004, 4: 32
    View at Publisher | View at Google Scholar
65. Lu DY, Huang M, Hu CX, Yang WY, Hu CX, Lin LP et al: Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines. BMC Pharmacology, 2005, 5:11
    View at Publisher | View at Google Scholar
66. Lu DY, Chen XL, Ding J. Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Medical Hypotheses. 2007, 68(1): 188-193
    View at Publisher | View at Google Scholar
67. Lu DY, Lu TR Antimetastatic activities and mechanisms of bisdioxopiperazine compounds. Anti-Cancer Agent Medicinal Chemistry. 2010, 10(7): 564-570
    View at Publisher | View at Google Scholar
68. Lu DY, Chen YZ, Lu TR, Xu B, Lu DF. Cancer metastasis, palliative treatment and Nursery. Annals Pharmacology Pharmaceutics. 2020, 5 (1), 1175
    View at Publisher | View at Google Scholar
69. Lu DY, Lu TR. Herbal medicine in new era. Hospice Palliative Medicine International J. 2019, 3 (4), 125-130
    View at Publisher | View at Google Scholar
70. Yang G, Li X, Li X, Wang L, Li J, Song X, Chen J, Guo Y, Sun X, Wang S, Zhang Z, Zhou X, Liu J. Traditional Chinese medicine in cancer care: a review of case series published in the Chinese literature. Evid Based Complement Alternate Med. 2012, 751046; doi:10.1155/2012/751046
    View at Publisher | View at Google Scholar
71. Lu DY, Lu TR, Putta S, Xu B, Wu HY. Anticancer drug discoveries from herbal medicine. EC Pharmacology Toxicology. 2019, 7 (9), 990-994
    View at Publisher | View at Google Scholar
72. Pattanayak S. Alternative to antibiotics from herbal origin—outline of a comprehensive research project. Current Pharmacogenomics Personalized Medicine. 2018, 16 (1), 9-62
    View at Publisher | View at Google Scholar
73. Parasuraman S. Herbal drug discovery: challenges and perspectives. Current Pharmacogenetics Personalized Medicine. 2018, 16 (1), 63-68
    View at Publisher | View at Google Scholar
74. Lu DY, Lu TR. Herbal medicine in new era. Hospice Palliative Medicine International J. 2019, 3 (4), 125-130
    View at Publisher | View at Google Scholar
75. Lu DY, Lu TR, Yarla NS, Lu Y, Che JY, Ding J, Xu B, Zhu H, Shen Y, Wu HY. Natural drug cancer treatment strategies from herbal medicine to chemical or biological drug. Studies in Natural Products Chemistry. Bioactive Natural Products. 2020, 66, 91-115
    View at Publisher | View at Google Scholar